// App-Quantinova.ai

1425 : Prospective evaluation of serum unbound fraction of docetaxel as a key determinant of its pharmacokinetics and neutropenia in the elderly

Researchers

Presenter

  • Hirotsugu Kenmotsu

Principal Investigators

  • Chiyo K. Imamura

  • Akira Ono

  • Shota Omori

  • Kazuhisa Nakashima

  • Kazushige Wakuda

  • Tetsuhiko Taira

  • Tateaki Naito

  • Haruyasu Murakami

  • Toshiaki Takahashi

  • Yusuke Tanigawara

Medical Centers

  • Shizuoka Cancer Center Hospital, Shizuoka, Japan

  • Keio University School of Medicine, Yokohama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Neutropenia

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved